首页> 外文OA文献 >NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.

【2h】

NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.

机译：核桃瘤：在先进的非小细胞肺癌中的幼肠病和立体定向烧蚀身体放射治疗的随机相2试验，在第一或二线化疗后进展。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Paul Mitchell; Shankar Siva; Peey Sei Kok; Ken OByrne; Annie Yeung; Ann Livingstone; Mark Donoghoe; Sonia Yip; Martin R. Stockler;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [J] . M. P. Snee, L. McParland, F. Collinson, Pilot and Feasibility Studies . 2016,第1期

机译：SABRTooth可行性试验方案：一项研究，用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除引起并发症的风险更高
2. SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial [J] . Landau D. B., Hughes L., Ngai Y., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第期

机译：Saron：脱象渗透非小细胞肺癌（NSCLC）的立体定向烧蚀疗法。英国随机阶段III审判
3. SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial [J] . Landau D. B., Hughes L., Ngai Y., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第Suppla1期

机译：Saron：脱象渗透非小细胞肺癌（NSCLC）的立体定向烧蚀疗法。英国随机阶段III审判
4. Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR) [C] . S Devpura, M S Siddiqui, D Chen, ICCR . 2014

机译：肺癌治疗计划剂量计算的建议（SABR）治疗肺癌治疗计划（SABR）
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Correction: Study protocol for the SARON trial: a multicentre randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer [O] . 2019

机译：更正：SARON试验的研究方案：一项多中心随机对照III期试验比较了针对少转移非小细胞肺癌的单纯立体定向消融放疗和根治性放疗与标准化疗的比较
7. Correction:Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer [O] . 2019

机译：矫正：培养试验的研究方案：多期，随机对照期III试验，比较了单定术烧蚀放疗和独立放疗，单独用单独的化疗进行寡核疗法非小细胞肺癌
8. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.

著录项

相似文献

相关主题

期刊订阅